Physician profile
Grant T Pierson
NPI 1699034900
$138,142.19
in general payments reported to CMS, 2019-2025
18 companies · $35K in 2025
The $35K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $253 · 2021: $1,748 · 2022: $22K · 2023: $39K · 2024: $39K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Consulting Fee: $46K · Travel and Lodging: $8,269 · Food and Beverage: $4,429 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,530.00 |
| Consulting Fee | $46,273.51 |
| Travel and Lodging | $8,269.14 |
| Food and Beverage | $4,429.28 |
| Education | $173.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $56,244.79 | 2020-2025 | Breztri, Airsupra, Tezspire |
| Medical Device Business Services, INC. | $30,218.97 | 2023-2025 | Monarch Platform, Monarch |
| Ethicon INC. | $25,587.57 | 2020-2025 | Monarch Platform |
| Ethicon Endo-Surgery INC. | $22,457.90 | 2022-2024 | Monarch Platform |
| Olympus America INC. | $1,500.00 | 2023-2024 | Spin Perc Localization Needle 19ga X 105mm, 1cm Marking Zone, Always-On Tip Tracked Forceps, 1.8mm Od, Serrated Cup, Spiration Valve System |
| Fujifilm Healthcare Americas Corporation | $546.00 | 2022-2023 | Fujifilm |
| Jazz Pharmaceuticals INC. | $436.89 | 2019-2025 | Xywav |
| Glaxosmithkline, LLC. | $257.66 | 2019-2022 | |
| Inspire Medical Systems, INC. | $185.21 | 2024-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $162.72 | 2021-2023 | Uptravi, Opsumit |
| Galvanize Therapeutics, INC | $156.27 | 2023 | Aliya System |
| Grifols USA, LLC | $112.91 | 2022-2023 | Prolastin-C Liquid |
| Veran Medical Technologies, INC. | $86.32 | 2021 | |
| United Therapeutics Corporation | $73.22 | 2022 | |
| Harmony Biosciences LLC | $62.45 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $22.54 | 2022 | |
| Organogenesis INC. | $19.46 | 2025 | Apligraf |
| Arbor Pharmaceuticals, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Pierson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.